Top 10 Medical Stocks To Watch For 2019

tags:STRA,XBI,NTAP,DBL,AVY,JJSF,REI,PVH,SJI,VVUS,

Redmile Group LLC decreased its position in InVitae Corp (NYSE:NVTA) by 3.7% in the first quarter, HoldingsChannel reports. The firm owned 2,139,520 shares of the medical research company’s stock after selling 82,520 shares during the quarter. Redmile Group LLC’s holdings in InVitae were worth $10,034,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. BlackRock Inc. raised its holdings in InVitae by 18.4% in the first quarter. BlackRock Inc. now owns 2,725,535 shares of the medical research company’s stock worth $12,782,000 after purchasing an additional 423,684 shares in the last quarter. Park West Asset Management LLC bought a new position in InVitae in the fourth quarter worth $23,916,000. ARK Investment Management LLC raised its holdings in InVitae by 44.1% in the fourth quarter. ARK Investment Management LLC now owns 2,104,798 shares of the medical research company’s stock worth $19,112,000 after purchasing an additional 643,860 shares in the last quarter. Perceptive Advisors LLC raised its holdings in InVitae by 6.4% in the fourth quarter. Perceptive Advisors LLC now owns 2,004,500 shares of the medical research company’s stock worth $18,200,000 after purchasing an additional 120,000 shares in the last quarter. Finally, Rock Springs Capital Management LP increased its holdings in shares of InVitae by 7.2% during the first quarter. Rock Springs Capital Management LP now owns 1,400,000 shares of the medical research company’s stock valued at $6,566,000 after acquiring an additional 94,000 shares in the last quarter. Institutional investors and hedge funds own 69.92% of the company’s stock.

Top 10 Medical Stocks To Watch For 2019: Strayer Education, Inc.(STRA)

Advisors' Opinion:

• [By Ethan Ryder]

  Strayer Education (NASDAQ: STRA) and New Oriental Education & Tech Grp (NYSE:EDU) are both consumer discretionary companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, earnings, institutional ownership and profitability.

• [By Joseph Griffin]

  Get a free copy of the Zacks research report on Strategic Education (STRA)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Stephan Byrd]

  Get a free copy of the Zacks research report on Strayer Education (STRA)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Stephan Byrd]

  Strayer Education (NASDAQ:STRA) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Strayer Education’s first-quarter 2018 earnings surpassed the Zacks Consensus Estimate and increased 29.5% year over year. Moreover, revenues improved 1.4% from the prior-year quarter’s figure, owing to higher winter term enrollment. Positive enrollment trend continued in the first quarter with new students and total enrollment up 6% each. Strayer’s convenient, accessible and flexible educational programs are designed to meet the educational needs of working adults. Strayer University is lowering the cost of its programs to enhance affordability. However, tuition cuts and an unfavorable mix of students toward lower undergraduate tuition have resulted in declining revenue per student over the past few quarters. Revenue per student declined approximately 5% in the first quarter of 2018. Importantly, Strayer and Capella decided to merge in an all-stock deal of equal transactions, expected to close in the third quarter of 2018.”

• [By Max Byerly]

  Strategic Education Inc (NASDAQ:STRA) has earned a consensus recommendation of “Hold” from the eight analysts that are presently covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and four have issued a buy recommendation on the company. The average twelve-month price target among analysts that have updated their coverage on the stock in the last year is $155.00.

• [By Ethan Ryder]

  Strayer Education (NASDAQ:STRA) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Strayer Education’s first-quarter 2018 earnings surpassed the Zacks Consensus Estimate and increased 29.5% year over year. Moreover, revenues improved 1.4% from the prior-year quarter’s figure, owing to higher winter term enrollment. Positive enrollment trend continued in the first quarter with new students and total enrollment up 6% each. Strayer’s convenient, accessible and flexible educational programs are designed to meet the educational needs of working adults. Strayer University is lowering the cost of its programs to enhance affordability. However, tuition cuts and an unfavorable mix of students toward lower undergraduate tuition have resulted in declining revenue per student over the past few quarters. Revenue per student declined approximately 5% in the first quarter of 2018. Importantly, Strayer and Capella decided to merge in an all-stock deal of equal transactions, expected to close in the third quarter of 2018.”

Top 10 Medical Stocks To Watch For 2019: SPDR S&P Biotech ETF (XBI)

Advisors' Opinion:

• [By Ethan Ryder]

  Investors purchased shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) on weakness during trading hours on Wednesday. $147.17 million flowed into the stock on the tick-up and $108.17 million flowed out of the stock on the tick-down, for a money net flow of $39.00 million into the stock. Of all companies tracked, SPDR S&P Biotech ETF had the 22nd highest net in-flow for the day. SPDR S&P Biotech ETF traded down ($2.97) for the day and closed at $85.44

• [By Jim Crumly]

  Biotech stocks notched big gains for the second straight day, with the SPDR S&P Biotech ETF (NYSEMKT:XBI) adding 2.3%. Retail stocks also were strong; the SPDR S&P Retail ETF (NYSEMKT:XRT) closed up 1%.

• [By Joe Tenebruso]

  In this regard, two biotech ETFs -- the iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) and the SPDR S&P Biotech ETF (NYSEMKT:XBI) -- stand out among the rest as particularly strong investment options. Read on to learn more about them.

• [By Jim Crumly]

  Biotech stocks made gains today, with the SPDR S&P Biotech ETF (NYSEMKT:XBI) rising 1.3%. Consumer stocks were the laggards; the Consumer Staples Select Sector SPDR ETF (NYSEMKT:XLP) fell 0.6%.

• [By Jim Crumly]

  Technology was the weakest sector, with biotech and semiconductor stocks in particular having a tough day. The SPDR S&P Biotech ETF (NYSEMKT:XBI) tumbled 3.2% and the iShares PHLX Semiconductor ETF (NASDAQ:SOXX) lost 2.4%.

Top 10 Medical Stocks To Watch For 2019: NetApp Inc.(NTAP)

Advisors' Opinion:

• [By Motley Fool Staff]

  NetApp, Inc. (NASDAQ:NTAP)Q4 2018 Earnings Conference CallMay 23, 2018, 5:00 p.m. ET

  Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

  Operator

• [By Chris Lange]

  When NetApp Inc. (NASDAQ: NTAP) released its third-quarter financial results before the markets opened on Thursday, the firm said that it had $1.20 in earnings per share (EPS) and $1.56 billion in revenue. Consensus estimates had called for $1.15 in EPS and $1.6 billion in revenue, and it the same period of last year NetApp said it had $0.99 in EPS and $1.52 billion in revenue.

• [By Jon C. Ogg]

  NetApp Inc. (NASDAQ: NTAP) was reiterated as Buy and the price target was raised to $90 from $76 at Argus. The firm noted that new offerings with Cisco in the FlexPod solutions have a big jump in health care and the firm came up with a blended analysis of earnings and valuation that could be north of $100 for the stock.

• [By Max Byerly]

  These are some of the news articles that may have impacted Accern Sentiment Analysis’s analysis:

  Get NetApp alerts: NetApp unveils Data Visionary Engineering Center (crn.in) NetApp strengthens cloud data services portfolio (it-online.co.za) NetApp Launches DVEC To Empower Customers, Partners (cxotoday.com) NetApp (NTAP) Checks Point To A Strong Quarter – BofA (streetinsider.com) Zacks: Brokerages Anticipate NetApp (NTAP) Will Announce Quarterly Sales of $1.60 Billion (americanbankingnews.com)

  Shares of NASDAQ NTAP traded up $0.44 during trading on Friday, hitting $72.27. The company had a trading volume of 1,689,731 shares, compared to its average volume of 3,005,906. The company has a quick ratio of 1.88, a current ratio of 1.91 and a debt-to-equity ratio of 0.71. NetApp has a 12 month low of $37.43 and a 12 month high of $72.81. The company has a market capitalization of $19.07 billion, a P/E ratio of 34.41, a price-to-earnings-growth ratio of 2.05 and a beta of 1.26.

Top 10 Medical Stocks To Watch For 2019: DoubleLine Opportunistic Credit Fund(DBL)

Advisors' Opinion:

• [By Max Byerly]

  News headlines about Doubleline Opportunistic Credit Fund common stock (NYSE:DBL) have been trending somewhat positive on Monday, according to Accern Sentiment. Accern identifies positive and negative news coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Doubleline Opportunistic Credit Fund common stock earned a news impact score of 0.04 on Accern’s scale. Accern also gave media stories about the investment management company an impact score of 47.2090833571026 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

• [By Logan Wallace]

  Doubleline Opportunistic Credit Fund common stock (NYSE:DBL) announced a monthly dividend on Friday, June 1st, Zacks reports. Investors of record on Thursday, June 14th will be paid a dividend of 0.167 per share by the investment management company on Friday, June 29th. This represents a $2.00 dividend on an annualized basis and a yield of 9.41%. The ex-dividend date is Wednesday, June 13th.

• [By Joseph Griffin]

  Doubleline Opportunistic Credit Fund (NYSE:DBL) declared a monthly dividend on Monday, October 1st, NASDAQ reports. Stockholders of record on Thursday, October 11th will be paid a dividend of 0.167 per share by the investment management company on Wednesday, October 31st. This represents a $2.00 annualized dividend and a dividend yield of 9.98%. The ex-dividend date of this dividend is Wednesday, October 10th.

Top 10 Medical Stocks To Watch For 2019: Avery Dennison Corporation(AVY)

Advisors' Opinion:

• [By Shane Hupp]

  Get a free copy of the Zacks research report on Avery Dennison (AVY)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Ethan Ryder]

  OMERS ADMINISTRATION Corp decreased its holdings in shares of Avery Dennison Corp (NYSE:AVY) by 9.7% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 69,500 shares of the industrial products company’s stock after selling 7,500 shares during the period. OMERS ADMINISTRATION Corp owned approximately 0.08% of Avery Dennison worth $7,096,000 as of its most recent SEC filing.

• [By Ethan Ryder]

  Calamos Advisors LLC raised its position in Avery Dennison Corp (NYSE:AVY) by 11.2% in the second quarter, Holdings Channel reports. The fund owned 40,597 shares of the industrial products company’s stock after buying an additional 4,088 shares during the period. Calamos Advisors LLC’s holdings in Avery Dennison were worth $4,145,000 as of its most recent SEC filing.

Top 10 Medical Stocks To Watch For 2019: J & J Snack Foods Corp.(JJSF)

Advisors' Opinion:

• [By Shane Hupp]

  Get a free copy of the Zacks research report on J & J Snack Foods (JJSF)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Trey Thoelcke]

  If Coca-Cola is interested in expanding into snacks to be more like rival PepsiCo Inc. (NASDAQ: PEP), one place to start may be with either J&J Snack Foods Corp. (NASDAQ: JJSF) or TreeHouse Foods Inc. (NYSE: THS). They both have market caps of less than $3 million. J&J products include pretzels, desserts and more, while TreeHouse offers various snacks, baked goods and condiments. Both also have beverage offerings.

• [By Ethan Ryder]

  Get a free copy of the Zacks research report on J & J Snack Foods (JJSF)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Joseph Griffin]

  Get a free copy of the Zacks research report on J & J Snack Foods (JJSF)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Medical Stocks To Watch For 2019: Ring Energy, Inc.(REI)

Advisors' Opinion:

• [By Matthew DiLallo]

  Shares of Ring Energy Inc. (NYSEMKT:REI) tumbled more than 19% by 2:30 p.m. EDT on Tuesday after an analyst downgraded the oil and gas producers' stock.

• [By Stephan Byrd]

  RioCan Real Estate Investment Trust (TSE:REI) announced a monthly dividend on Friday, September 14th, Zacks reports. Investors of record on Friday, September 28th will be given a dividend of 0.12 per share on Friday, October 5th. This represents a $1.44 dividend on an annualized basis and a yield of 8.45%. The ex-dividend date of this dividend is Thursday, September 27th.

• [By Stephan Byrd]

  Vanguard Group Inc. lifted its position in Ring Energy Inc (NYSEAMERICAN:REI) by 2.2% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,422,953 shares of the company’s stock after acquiring an additional 72,507 shares during the quarter. Vanguard Group Inc. owned 5.65% of Ring Energy worth $33,922,000 as of its most recent SEC filing.

• [By Joseph Griffin]

  Ring Energy Inc (NYSEAMERICAN:REI) – Investment analysts at B. Riley upped their Q3 2018 earnings estimates for Ring Energy in a research report issued on Tuesday, October 9th. B. Riley analyst R. Rashid now expects that the company will post earnings per share of $0.15 for the quarter, up from their previous forecast of $0.14. B. Riley also issued estimates for Ring Energy’s Q4 2018 earnings at $0.21 EPS and FY2018 earnings at $0.60 EPS.

Top 10 Medical Stocks To Watch For 2019: PVH Corp.(PVH)

Advisors' Opinion:

• [By Max Byerly]

  State of Alaska Department of Revenue grew its holdings in PVH Corp (NYSE:PVH) by 14.6% in the second quarter, HoldingsChannel reports. The institutional investor owned 22,780 shares of the textile maker’s stock after acquiring an additional 2,910 shares during the period. State of Alaska Department of Revenue’s holdings in PVH were worth $3,409,000 at the end of the most recent reporting period.

• [By Garrett Baldwin]

  By submitting your email address you will receive a free subscription to Profit Alerts and occasional special offers from Money Map Press and our affiliates. You can unsubscribe at anytime and we encourage you to read more about our privacy policy.

  Three Stocks to Watch Today: CRM, GOOGL, DKS Salesforce.com Inc. (NYSE: CRM) will report earnings after the bell. The cloud computing giant is expected to report earnings per share of $0.47 on top of $3.23 billion in revenue. With strong cloud-computing demand from businesses, expect a lot of anticipation around the company's third-quarter forecast and full-year outlook. Investors will also be looking for an update on the impact of its acquisition of MuleSoft, the largest deal in Salesforce history. The White House is pressuring Alphabet Inc. (Nasdaq: GOOGL) after President Trump accused the team behind the Google search engine of selective bias. Trump believes that Google has been hiding positive news about him, but he failed to provide any evidence to his claims. Trump's top economic advisor, Larry Kudlow, said the White House is "having a look" at Google, but didn't provide any details on the plan. Shares of Amazon.com Inc. (Nasdaq: AMZN) are on the move thanks to a big upgrade from Morgan Stanley (NYSE: MS). Analysts at the investment bank hiked their price target for AMZN stock to $2,500 per share. That figure would push the e-commerce giant's market capitalization to a whopping $1.2 trillion. This is the highest price target among the 41 analysts covering the stock, according to data from FactSet. Look for additional earnings reports from Dick's Sporting Goods Inc. (NYSE: DKS), American Eagle Outfitters Inc. (NYSE: AEO), PVH Corp. (NYSE: PVH), Guess? Inc. (NYSE: GES), Express Inc. (Nasdaq: EXPR), and Tilly's Inc. (Nasdaq: TLYS).

  Follow Money Morning on Facebook, Twitter, and LinkedIn.

• [By ]

  In the mid-level, Boss said that Urban Outfitters (URBN) is recovering, along with Kohl's Stores (KSS) . He also liked PVH (PVH) and Lululemon Athletica (LULU) .

• [By Joseph Griffin]

  Dynamic Technology Lab Private Ltd grew its holdings in PVH Corp (NYSE:PVH) by 60.6% during the first quarter, HoldingsChannel.com reports. The firm owned 3,078 shares of the textile maker’s stock after acquiring an additional 1,162 shares during the quarter. Dynamic Technology Lab Private Ltd’s holdings in PVH were worth $467,000 at the end of the most recent quarter.

• [By Shane Hupp]

  ILLEGAL ACTIVITY WARNING: “Atlas Capital Advisors LLC Has $249,000 Stake in PVH Corp (PVH)” was published by Ticker Report and is the sole property of of Ticker Report. If you are reading this piece on another website, it was illegally stolen and reposted in violation of United States & international copyright and trademark law. The correct version of this piece can be viewed at https://www.tickerreport.com/banking-finance/4116969/atlas-capital-advisors-llc-has-249000-stake-in-pvh-corp-pvh.html.

• [By ]

  Perhaps seeing the names of these companies begins to spark some memories. In short, clothing retailer PVH (NYSE: PVH) and beverage company Constellation Brands (NYSE: STZ) were taking heat over the rhetoric of a possible "Border Tax" -- a tax on goods made overseas and imported and sold in the United States.

Top 10 Medical Stocks To Watch For 2019: South Jersey Industries Inc.(SJI)

Advisors' Opinion:

• [By Ethan Ryder]

  South Jersey Industries (NYSE: SJI) and Engie (OTCMKTS:ENGIY) are both utilities companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, analyst recommendations, earnings, dividends, institutional ownership and profitability.

• [By Stephan Byrd]

  South Jersey Industries (NYSE:SJI) was upgraded by equities researchers at ValuEngine from a “sell” rating to a “hold” rating in a report issued on Wednesday.

• [By Logan Wallace]

  Shares of South Jersey Industries Inc (NYSE:SJI) have received an average recommendation of “Hold” from the twelve ratings firms that are currently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and two have assigned a buy rating to the company. The average 12 month price objective among brokers that have issued ratings on the stock in the last year is $34.00.

• [By Shane Hupp]

  Get a free copy of the Zacks research report on South Jersey Industries (SJI)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Ethan Ryder]

  Get a free copy of the Zacks research report on South Jersey Industries (SJI)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Medical Stocks To Watch For 2019: VIVUS, Inc.(VVUS)

Advisors' Opinion:

• [By Logan Wallace]

  Media stories about VIVUS (NASDAQ:VVUS) have been trending somewhat positive recently, according to Accern Sentiment. The research group ranks the sentiment of news coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. VIVUS earned a news impact score of 0.13 on Accern’s scale. Accern also gave press coverage about the biopharmaceutical company an impact score of 47.022479468622 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

• [By Money Morning News Team]

  Seadrill's rally demonstrates how profitable penny stocks can be for savvy investors. With Seadrill's gains already on the books, we'll look at a stock that's on track to generate tremendous returns – a small cap that just completed a groundbreaking acquisition with huge profit potential…

  Penny Stock Current Share Price Law Week's Gain Seadrill Ltd. (NYSE: SDRL) $0.58 98.74% Vivis Inc. (Nasdaq: VVUS) $0.83 59.97% MEI Pharma Inc. (Nasdaq: MEIP) $3.45 43.40% Transenterix Inc. (NYSE: TRXC) $3.15 35.72% Akers Biosciences Inc. (Nasdaq: AKER) $0.65 34.38% Galectin Therapeutics Inc. (Nasdaq: GALT) $4.54 32.58% Phoenix New Media Ltd. (NYSE ADR: FENG) $5.65 32.22% Heat Biologics Inc. (Nasdaq: HTBX) $1.73 31.37% Bright Scholar Education Ltd. (NYSE ADR: BEDU) $18.51 29.03% 21 Vianet Group Inc. (Nasdaq: VNET) $7.36 28.72%

  These gains are incredibly exciting. However, not all penny stocks are equally strong investments.

• [By Ethan Ryder]

  Get a free copy of the Zacks research report on VIVUS (VVUS)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Money Morning Staff Reports]

  But Blink and our other penny stocks to watch are unlikely to continue to lock in such spectacular gains in June. After looking at our 10 top penny stocks to watch this month, we'll show you a small-cap stock with great profit potential in its future…

  Penny Stock Current Share Price Law Month's Gain  Blink Charging Co. (Nasdaq: BLNK) $7.07 439.85% Senes Tech Inc. (Nasdaq: SNES) $1.27 175.40% Vivis Inc. (Nasdaq: VVUS) $0.77 150.41% Adomani Inc. (Nasdaq: ADOM) $1.49 137.68% NF Energy Saving Co. (Nasdaq: NFEC) $2.34 134.88% Vaalco Energy Inc. (NYSE: EGY) $2.15 109.06% Heat Biologics Inc. (Nasdaq: HTBX) $2.35 99.12% ArQule Inc. (Nasdaq: ARQL) $4.88 90.74% LiqTech International Inc. (NYSE: LIQT) $0.66 85.60% Transenterix Inc. (NYSE: TRXC) $3.46 77.84%

  While last month's gains are tremendous, they also illustrate the inherent dangers that come with investing in penny stocks.

• [By Logan Wallace]

  Get a free copy of the Zacks research report on VIVUS (VVUS)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Money Morning News Team]

  However, VivoPower and our other penny stocks to watch this week already saw big gains. After looking at our 10 top penny stocks to watch, we'll show you a small-cap stock with serious profit potential in its future…

  Penny Stock Current Share Price Law Week's Gain VivoPower International Plc. (Nasdaq: VVPR) $3.05 88.57% Euro Tech Holdings Co. (Nasdaq: CLWT) $3.77 75.11% Boxlight Corp. (Nasdaq: BOXL) $6.36 65.38% Chine Recycling Energy Corp. (Nasdaq: CREG) $2.01 45.92% Vivis Inc. (Nasdaq: VVUS) $0.52 38.82% HC2 Holdings Inc. (NYSE: HCHC) $6.79 33.49% Biostar Pharmaceuticals Inc. (Nasdaq: BSPM) $2.67 32.23% Turtle Beach Corp. (Nasdaq: HEAR) $6.99 30.19% Aegean Marine Petroleum Network Inc. (NYSE: ANW) $3.30 29.24% Rexahn Pharmaceuticals Inc. (NYSE: RNN) $2.11 29.19%

  While the gains of last week's top penny stocks are exciting, it's important to note that investing in penny stocks is also incredibly risky.